New Delhi, Aug 3 (UNI) The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II and III clinical trials of Oxford University-Astra Zeneca Covid-19 vaccine (COVISHIELD) in the country.
This will hasten the development of the Covid-19 vaccine, the Ministry of Health and Family Welfare said in a release here.
India has seen more than 40,574 patients recovered in the past 24 hours taking the total recoveries to 11,86,203 and Recovery Rate to 65.77 per cent among Covid-19 patients.